Table 1.
Characteristic | Main Sample (N = 526) | Subseta (N = 150) | ||||
---|---|---|---|---|---|---|
Mean (SD) | Range | Mean (SD) | Range | |||
Age at last interview/W6 | 32.5 (16.1) | 4.4–67.9 | 31.3 (15.2) | 6.0–59.1 | ||
N (%) | N (%) | |||||
Generation (G) | ||||||
G2 | 273 (51.9) | 63 (42.0) | ||||
G3 | 253 (48.1) | 87 (58.0) | ||||
Sex | ||||||
Female | 279 (53.0) | 78 (52.0) | ||||
Male | 247 (47.0) | 72 (48.0) | ||||
Familial Risk Status | ||||||
High Risk | 354 (67.3) | 90 (60.0) | ||||
Low Risk | 172 (32.7) | 60 (40.0) | ||||
Lifetime MDD | ||||||
Yes | 217 (41.3) | 78 (52.0) | ||||
No | 309 (58.7) | 72 (48.0) | ||||
Medical Disorder | Yes | No | Unknown | Yes | No | |
Lipid-Associated Medical Disorder (LAMD) | 139 (26.4) | 387 (73.6) | 0 | 52 (34.7) | 98 (65.3) | |
Hypertension | 70 (13.3) | 434 (82.5) | 22 (4.2) | 25 (16.7) | 125 (83.3) | |
Cardiovascular | 42 (8.0) | 479 (91.1) | 5 (0.9) | 13 (8.7) | 137 (91.3) | |
Hyperthyroidism | 12 (2.3) | 514 (97.7) | 0 | 4 (2.7) | 146 (97.3) | |
Hypothyroidism | 28 (5.3) | 480 (91.3) | 18 (3.4) | 13 (8.7) | 137 (91.3) | |
Gallbladder disease | 18 (3.4) | 477 (90.7) | 31 (5.9) | 8 (5.3) | 142 (94.7) | |
Diabetes | 21 (4.0) | 487 (92.6) | 18 (3.4) | 8 (5.3) | 142 (94.7) | |
Lipid Independent Medical Disorder (LIMD) (cancer) | 37 (7.0) | 489 (93.0) | 0 | 15 (10.0) | 135 (90.0) | |
Intermediately Associated Medical Disorder (IAMD) | 108 (20.5) | 418 (79.5) | 0 | 29 (19.3) | 121 (80.7) | |
Convulsion | 19 (3.6) | 507 (96.4) | 0 | 3 (2.0) | 147 (98.0) | |
Head injury | 57 (10.8) | 469 (89.2) | 0 | 22 (14.7) | 128 (85.3) | |
Stroke | 41 (7.8) | 485 (92.2) | 0 | 7 (4.7) | 143 (95.3) |
aThe subjects who had records of Similarities subtest T-scores and Verbal IQ sum of T-scores at W6.